IDXX
IDEXX Laboratories Inc
522.00$
+0.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.3% | +54.6% | +11.6% | +7.2% | +14.8% | +41.1% | +16.6% | -28.1% | +66.9% | +2.5% | +26.8% | |
| – | +17.1% | +13.4% | +6.3% | +0.0% | +5.8% | +9.1% | +9.0% | +7.0% | +2.7% | +13.1% | +11.7% | |
| – | +9.9% | +0.0% | +18.2% | +7.0% | +56.1% | -21.2% | +22.0% | +31.8% | +20.0% | +0.9% | -0.5% | |
| – | +400.5% | +28.8% | -39.4% | +70.8% | +53.4% | -96.5% | +8,644.8% | -82.8% | – | – | – | |
| – | – | – | +179.1% | -1,193.6% | – | – | – | – | – | – | – | |
| – | +36.6% | -21.9% | +18.4% | +60.3% | +26.3% | -30.7% | +11.1% | +24.5% | -10.2% | -2.0% | -4.8% | |
| – | +283.5% | -70.6% | +52.8% | – | -248.3% | -46.8% | +167.9% | -33.3% | -35.9% | +65.3% | -34.2% | |
| – | – | – | – | – | – | +42.2% | -9.3% | – | – | – | – | |
| – | -35.0% | -24.4% | -4.4% | +27.1% | -18.3% | -39.4% | +308.5% | +9.8% | -91.2% | +1,063.8% | +45.4% | |
| – | -41.9% | -86.1% | +16.0% | -681.9% | -95.9% | +807.6% | – | +1,730.1% | -193.9% | -81.4% | -59.5% | |
| – | -7.6% | +128.0% | -4.5% | +187.4% | -52.1% | -13.3% | +180.7% | -46.8% | +19.2% | +98.7% | +32.2% | |
| – | -545.1% | – | +26.5% | -294.9% | – | – | -181.6% | – | – | -148.5% | – | |
| – | -23.8% | +102.2% | +9.9% | -6.5% | +9.7% | +77.8% | +17.7% | -38.0% | +96.1% | +3.3% | +32.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.